Pac Premier
Giving Guide
You are here:  Home  >  Biotech  >  Current Article

Dyve Biosciences gout treatment shows promise

By   /   Friday, March 22nd, 2019  /   Comments Off on Dyve Biosciences gout treatment shows promise

    Print       Email
A human study of a topical gout pain product from Thousand Oaks-based Dyve Biosciences returned positive results, the company announced March 20. The results of the double-blind proof-of-concept pilot study were presented at a workshop at the European Crystal Network in Paris March 14-15. Dyve products aim to deliver known molecules like sodium bicarbonate –…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email